Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Trump Says Tariffs Pushed Novartis to Expand Operations in US
Trump Says Tariffs Pushed Novartis to Expand Operations in US
Fabienne Kinzelmann
Fri, February 20, 2026 at 7:00 PM GMT+9 1 min read
In this article:
NVS
-0.88%
(Bloomberg) – President Donald Trump said his tariffs spurred Novartis AG to expand its US manufacturing footprint, following a meeting with the Swiss drugmaker’s chief executive Vas Narasimhan at the White House on Wednesday.
Speaking to workers at a steel plant in Rome, Georgia, on Thursday, Trump said Narasimhan told him the company was building new US plants as a result of the president’s tariff policies.
Most Read from Bloomberg
“We appreciate the opportunity to update the US government on our progress, including recent groundbreakings for manufacturing and research facilities in North Carolina and California and plans to expand our radioligand therapy manufacturing network with a new site in Florida,“ a spokesperson for Novartis said in an emailed statement. The statement didn’t include any figures.
Last year, Novartis said it would invest $23 billion to build and expand 10 facilities in the US. The move came following threats from the Trump administration to impose tariffs on imported medicines.
Novartis and the White House reached a deal shortly before Christmas aimed at lowering US drug prices, with the Swiss drugmaker agreeing to launch new medicines at prices comparable to those in other wealthy countries and to sell some treatments directly to patients through a government-backed platform. The company also plans to seek broader Medicaid discounts while continuing to invest in US manufacturing and research.
Most Read from Bloomberg Businessweek
©2026 Bloomberg L.P.
Terms and Privacy Policy
Privacy Dashboard
More Info